Net Change in Cash
Amgen Net Change in Cash decreased by 122.3% to -$316.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 110.7%, from $2.96B to -$316.00M. Over 2 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a 181.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cashHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $518.00M | $5.34B | -$1.46B | -$1.33B | $4.30B | -$1.87B | $23.93B | $2.69B | $493.00M | -$1.24B | -$407.00M | -$290.00M | $2.96B | -$3.16B | -$782.00M | $1.42B | -$316.00M |
| QoQ Change | — | +930.7% | -127.4% | +9.3% | +424.5% | -143.6% | >999% | -88.8% | -81.7% | -350.7% | +67.1% | +28.7% | >999% | -206.8% | +75.3% | +281.2% | -122.3% |
| YoY Change | — | — | — | -355.8% | -19.5% | — | >999% | +302.9% | -88.5% | -105.2% | -115.1% | -158.8% | — | -155.9% | -92.1% | +588.6% | -110.7% |
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Amgen's net change in cash?
- Amgen (AMGN) reported net change in cash of -$316.00M in Q4 2025.
- How has Amgen's net change in cash changed year-over-year?
- Amgen's net change in cash decreased by 110.7% year-over-year, from $2.96B to -$316.00M.
- What is the long-term trend for Amgen's net change in cash?
- Over 2 years (2022 to 2025), Amgen's net change in cash has grown at a 181.1% compound annual growth rate (CAGR), from -$360.00M to -$2.84B.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.